NCT01851512: A Study to Evaluate the Tolerability, Safety and Pharmacokinetic Characteristics of DA-3803 |
|
|
| Completed | 1 | 27 | RoW | T-R (Test-Reference drug), Drug: DA-3803 (Test drug), Drug: Ovidrel liquid injection (Referecne drug), R-T (Reference-Test drug) | Dong-A Pharmaceutical Co., Ltd. | Infertility, Induction of Ovulation | 08/10 | 04/11 | | |
NCT01422733: Effect of Longer-term Adrenal Suppression Using Low Dose Hydrocortisone on Androgen Overproduction |
|
|
| Withdrawn | 1 | 0 | US | Hydrocortisone, dexamethasone, Cosyntropin, Tetracosactide, rhCG, (Ovidrel) | University of Virginia | Hyperandrogenemia, Obesity, Polycystic Ovary Syndrome | 07/18 | 07/18 | | |
